According to LIMRA research, the life-combination market has grown to more than a $4 billion market over the past 10 years. A study, conducted jointly by LIMRA and Ernst & Young LLP (EY), identified five factors that impact the viability of the life-combination market.
The report, Combination Products: A One-Stop Solution? examines five factors that challenge life insurers’ ability to develop and market products that appeal to advisors and consumers, while still being profitable. They are:
Long term care (LTC) is a growing concern in the U.S. According to Health and Human Services, half of people turning 65 today will require some form of LTC support during their lives. With the average annual cost for nursing home care at close to $100,000 per year, few people have the resources to pay for this care and even fewer have insurance to mitigate these costs.
“Today more than 30 companies offer life-combination products, more than double the number a decade ago,” noted Scott Kallenbach, research director, LIMRA Strategic Research. “Our research shows consumers – especially younger consumers – like the idea of purchasing a product that can serve two purposes: mitigate the costs of long term care services or offer a death benefit. Based on the current sales trajectory of these products, we forecast this market to continue to enjoy robust growth.”
This report was supported by a quantitative survey conducted by LIMRA and EY last year. There were 45 participating companies, including 29 currently active in the combination product market, four that plan to enter the market within six months, and 12 that are not currently in the market and have no plans to enter it. During the first quarter of 2018, 20 one-on-one interviews were conducted with companies that are active in the market or planning to enter it within six months of the interview.
LIMRA and Ernst & Young LLP